Statistical Considerations for Subgroup Analyses.
作者信息
Wang Xiaofei, Piantadosi Steven, Le-Rademacher Jennifer, Mandrekar Sumithra J
机构信息
Department of Biostatistics & Bioinformatics, Duke University, Durham, North Carolina.
Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.
出版信息
J Thorac Oncol. 2021 Mar;16(3):375-380. doi: 10.1016/j.jtho.2020.12.008. Epub 2020 Dec 26.
Abstract
摘要
相似文献
1
Statistical Considerations for Subgroup Analyses.亚组分析的统计学考量
J Thorac Oncol. 2021 Mar;16(3):375-380. doi: 10.1016/j.jtho.2020.12.008. Epub 2020 Dec 26.
2
Subgroup identification for treatment selection in biomarker adaptive design.生物标志物适应性设计中用于治疗选择的亚组识别
BMC Med Res Methodol. 2015 Dec 9;15:105. doi: 10.1186/s12874-015-0098-7.
3
Futility for subgroup analyses in the adaptive signature design.适应性特征设计中亚组分析的无效性。
Stat Methods Med Res. 2019 Mar;28(3):953-961. doi: 10.1177/0962280217739659. Epub 2017 Nov 27.
4
Phase II trial design considerations for small-cell lung cancer.小细胞肺癌的II期试验设计考量
J Natl Cancer Inst. 1992 Feb 5;84(3):150-4. doi: 10.1093/jnci/84.3.150.
5
Comments on "Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials".关于《确证性临床试验亚组分析的统计学考量教程》的评论
Stat Med. 2018 Aug 30;37(19):2900-2901. doi: 10.1002/sim.7678. Epub 2018 Jul 16.
6
Importance of designing sample size, subgroup analysis, and covariate presentation: Towards a better randomized controlled trial.设计样本量、亚组分析和协变量呈现的重要性：迈向更好的随机对照试验。
Lung Cancer. 2021 Nov;161:200. doi: 10.1016/j.lungcan.2021.06.007. Epub 2021 Jun 5.
7
A reply to "Importance of designing sample size, subgroup analysis, and covariate presentation: Towards a better randomized controlled trial".对《设计样本量、亚组分析和协变量呈现的重要性：迈向更好的随机对照试验》的回复
Lung Cancer. 2021 Nov;161:201. doi: 10.1016/j.lungcan.2021.08.021. Epub 2021 Sep 11.
8
The lack of statistical power of subgroup analyses in meta-analyses: a cautionary note.荟萃分析中亚组分析缺乏统计学效能：警示
Epidemiol Psychiatr Sci. 2021 Dec 2;30:e78. doi: 10.1017/S2045796021000664.
9
Data-Driven Subgroup Identification in Confirmatory Clinical Trials.确证性临床试验中基于数据的亚组识别
Ther Innov Regul Sci. 2022 Jan;56(1):65-75. doi: 10.1007/s43441-021-00329-1. Epub 2021 Jul 29.
10
Considerations in designing and analyzing surgical adjuvant study in resected stage I and II carcinoma of the lung.关于设计和分析I期和II期肺癌切除术后辅助治疗研究的考量因素。
Cancer. 1979 Oct;44(4):1201-10. doi: 10.1002/1097-0142(197910)44:4<1201::aid-cncr2820440406>3.0.co;2-a.
引用本文的文献
1
Treatment modifiers and predictors of risperidone response in dementia: An individual participant data meta-analysis of six randomized controlled trials.痴呆症中利培酮反应的治疗修饰因素和预测因素：六项随机对照试验的个体参与者数据荟萃分析
Alzheimers Dement. 2025 Sep;21(9):e70665. doi: 10.1002/alz.70665.
2
Monocyte Distribution Width for Sepsis Diagnosis in the Emergency Department and Intensive Care Unit: A Systematic Review and Meta-Analysis.急诊科和重症监护病房中用于脓毒症诊断的单核细胞分布宽度：一项系统评价和荟萃分析
Int J Mol Sci. 2025 Aug 1;26(15):7444. doi: 10.3390/ijms26157444.
3
Impact of E-cigarette Use on Cardiovascular Risk Markers in Elderly Former Smokers: A Systematic Review and Meta-Analysis.电子烟使用对老年戒烟者心血管风险标志物的影响：一项系统评价和荟萃分析
Cureus. 2025 Jul 10;17(7):e87666. doi: 10.7759/cureus.87666. eCollection 2025 Jul.
4
Effect of a generalized early mobilization and rehabilitation protocol on outcomes in trauma patients admitted to the intensive care unit: a retrospective pre-post study.综合早期活动与康复方案对入住重症监护病房的创伤患者预后的影响：一项回顾性前后对照研究
Crit Care. 2025 Jul 30;29(1):337. doi: 10.1186/s13054-025-05570-w.
5
Immunotherapy combined with radiotherapy in the treatment of lung cancer: a meta-analysis of therapeutic effectiveness, safety considerations, and abscopal effect.免疫疗法联合放射疗法治疗肺癌：治疗效果、安全性考量及远隔效应的荟萃分析
BMC Cancer. 2025 Jul 17;25(1):1184. doi: 10.1186/s12885-025-14542-w.
6
Association between Diurnal Temperature Range, Daily Mean Temperature and Sarcopenia States in Older Adults: Evidence from the CHARLS.老年人昼夜温差、日平均温度与肌肉减少症状态之间的关联：来自中国健康与养老追踪调查（CHARLS）的证据
BMC Geriatr. 2025 Jul 15;25(1):531. doi: 10.1186/s12877-025-06179-y.
7
Role of zinc finger protein 71 in hepatocellular carcinoma: Methodological concerns, clinical relevance, and future directions.锌指蛋白71在肝细胞癌中的作用：方法学问题、临床相关性及未来方向。
World J Hepatol. 2025 Jun 27;17(6):106573. doi: 10.4254/wjh.v17.i6.106573.
8
Identifying clinically relevant subgroups of patients with knee pain flares for ibuprofen treatment: a secondary analysis.识别布洛芬治疗膝关节疼痛发作患者的临床相关亚组：一项二次分析
Clin Rheumatol. 2025 Jun 25. doi: 10.1007/s10067-025-07539-0.
9
Impact of resistance training intensity on body composition and nutritional intake among college women with overweight and obesity: a cluster randomized controlled trial.阻力训练强度对超重和肥胖女大学生身体成分及营养摄入的影响：一项整群随机对照试验
Front Public Health. 2025 May 30;13:1589036. doi: 10.3389/fpubh.2025.1589036. eCollection 2025.
10
Comments on "Evaluation of an Exercise Program in Patients with Inflammatory Bowel Disease: A Pilot Study".对“炎症性肠病患者运动计划的评估：一项试点研究”的评论
Dig Dis Sci. 2025 May 2. doi: 10.1007/s10620-025-09085-w.
本文引用的文献
1
Guidelines for Statistical Reporting in Medical Journals.医学期刊统计报告的准则。
J Thorac Oncol. 2020 Nov;15(11):1722-1726. doi: 10.1016/j.jtho.2020.08.019. Epub 2020 Aug 25.
2
Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions.《可信系统评价的更新指南：干预措施系统评价的新版Cochrane手册》
Cochrane Database Syst Rev. 2019 Oct 3;10(10):ED000142. doi: 10.1002/14651858.ED000142.
3
On Enrichment Strategies for Biomarker Stratified Clinical Trials.关于生物标志物分层临床试验的富集策略
J Biopharm Stat. 2018;28(2):292-308. doi: 10.1080/10543406.2017.1379532. Epub 2017 Oct 30.
4
Multiplicity considerations in subgroup analysis.亚组分析中的多重性考量
Stat Med. 2017 Dec 10;36(28):4446-4454. doi: 10.1002/sim.7416. Epub 2017 Aug 1.
5
Tutorial on statistical considerations on subgroup analysis in confirmatory clinical trials.确证性临床试验中亚组分析的统计学考量教程。
Stat Med. 2017 Apr 15;36(8):1334-1360. doi: 10.1002/sim.7167. Epub 2016 Nov 28.
6
Tutorial in biostatistics: data-driven subgroup identification and analysis in clinical trials.生物统计学教程：临床试验中数据驱动的亚组识别与分析
Stat Med. 2017 Jan 15;36(1):136-196. doi: 10.1002/sim.7064. Epub 2016 Aug 3.
7
Biomarker: Predictive or Prognostic?生物标志物：预测性还是预后性？
J Clin Oncol. 2015 Nov 20;33(33):3968-71. doi: 10.1200/JCO.2015.63.3651. Epub 2015 Sep 21.
8
Methods for identification and confirmation of targeted subgroups in clinical trials: A systematic review.临床试验中靶向亚组的识别与确认方法：一项系统评价
J Biopharm Stat. 2016;26(1):99-119. doi: 10.1080/10543406.2015.1092034.
9
General guidance on exploratory and confirmatory subgroup analysis in late-stage clinical trials.晚期临床试验中探索性和确证性子组分析的一般指南。
J Biopharm Stat. 2016;26(1):71-98. doi: 10.1080/10543406.2015.1092033.
10
Comparison of statistical analysis plans in randomize-all phase III trials with a predictive biomarker.伴有预测性生物标志物的随机 III 期试验中统计分析计划的比较。
Clin Cancer Res. 2014 Jun 1;20(11):2820-30. doi: 10.1158/1078-0432.CCR-13-2698. Epub 2014 Apr 1.
Zotero 插件